or Try an Advanced Search...

    ETF Components for AGNG - Global X Aging Population ETF


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    WELL A -1.19 3.91
    BSX C -0.48 3.47
    LLY F -1.30 3.25
    AMGN C -0.29 3.22
    ABBV A -0.16 3.06
    AZN F 0.38 3.03
    MDT B 0.92 3.01
    JNJ D 0.17 2.98
    BMY A -2.60 2.92
    SYK A 3.05 2.87
    REGN F 0.64 2.84
    VTR B -1.99 2.14
    EW D 0.79 2.06
    ZBH C 0.33 1.75
    BGNE C 0.77 1.73
    UTHR A 0.01 1.43
    DXCM C -0.18 1.42
    PODD A 1.76 1.36
    INCY A 2.71 1.21
    DVA D 1.27 1.17
    EXAS A 1.26 1.05
    NBIX C 1.61 0.95
    TFX F 5.05 0.91
    OHI B -2.99 0.83
    EXEL A 2.77 0.71
    ENSG A -0.43 0.69
    HALO B 13.01 0.54
    GKOS B -0.36 0.53
    MMSI B 0.14 0.45
    BPMC C 3.65 0.43
    MNKD A 1.41 0.42
    AGIO B 0.99 0.40
    SBRA B -3.92 0.37
    DNLI C 4.20 0.37
    NHC C 2.99 0.36
    NHI C -0.26 0.35
    EMBC C 1.21 0.35
    ITGR D 1.77 0.34
    NVCR F 6.59 0.31
    LTC A -2.36 0.30
    AMED C 0.94 0.28
    TBPH C 0.49 0.26
    LIVN C -0.95 0.26
    BKD D -0.32 0.25
    ACAD F 1.51 0.23
    ALEC D 2.03 0.20
    AGL F 5.88 0.14
    ATEC C 3.31 0.10

    Represented by ETF Holdings

    Keywords: S&P 500 Medicine Biopharmaceutical Cancer Diabetes Assisted Living Catheter Alzheimer's Disease Biotechnology Bone Hypertension Insulin Nasdaq 100 Neuroscience Pain Real Estate Investment Trust Schizophrenia Spine Cardiology Caregiving
    Industries: Biotechnology Medical Devices Drug Manufacturers - Major REIT - Healthcare Facilities Medical Instruments & Supplies Long-Term Care Facilities Diagnostics & Research Medical Care Drug Manufacturers - Specialty & Generic Medical Care Facilities

    Recent News for Global X Aging Population ETF & its Holdings

    Date Stock Title
    Nov 2 INCY What Moved Markets This Week
    Nov 1 MDT Medtronic (MDT) Outperforms Broader Market: What You Need to Know
    Nov 1 LLY Lilly to Present Results from Phase 3 EMBER-3 Study of Imlunestrant, an Oral SERD, and Additional Results from Its Breast Cancer Portfolio at the San Antonio Breast Cancer Symposium
    Nov 1 MDT CMS grants Transitional Pass-Through Payment for Medtronic Symplicity Spyral™ renal denervation catheter
    Nov 1 LLY Market Volatility Soars Ahead Of Elections, Tech Earnings Mixed, Strikes And Hurricanes Knock Employment Down: This Week In The Markets
    Nov 1 LLY Madrigal Catapults After Novo's Wegovy Proves It's No 'Silver Bullet' In MASH
    Nov 1 JNJ Stocks that hedge funds moved from long to short in August - Jefferies
    Nov 1 BMY Bristol Myers Squibb Stock Gets Relative Strength Rating Upgrade
    Nov 1 ABBV Bristol Myers Squibb Stock Gets Relative Strength Rating Upgrade
    Nov 1 AGIO Deep Dive Into Alnylam Pharmaceuticals Stock: Analyst Perspectives (6 Ratings)
    Nov 1 LLY Pharma Stock Roundup: MRK, PFE, ABBV, NVS, LLY's Q3 Earnings in Focus
    Nov 1 ABBV Pharma Stock Roundup: MRK, PFE, ABBV, NVS, LLY's Q3 Earnings in Focus
    Nov 1 HALO Top High Growth Tech Stocks To Watch In November 2024
    Nov 1 DXCM DexCom (DXCM) Fell Due to an Uncharacteristic Earnings Miss
    Nov 1 LLY Stocks to watch next week: Berkshire Hathaway, Super Micro, Novo Nordisk, Vistry and M&S
    Nov 1 HALO Halozyme Announces Record Earnings, Guidance
    Nov 1 ENSG Ensign Group Q3 Earnings Beat on Patient Days, Stock Up 4.1%
    Nov 1 LLY Hims & Hers Health Faces Pressure Ahead of Earnings Amid Eli Lilly's GLP-1 News
    Nov 1 AGIO AGIO's Q3 Earnings Miss Mark, Revenues In Line, Stock Down
    Nov 1 BMY Bristol Myers posts long-term Phase 3 data for schizophrenia drug Cobenfy
    The investment seeks results that correspond generally to the price and yield performance, before fees and expenses, of the Indxx Global Longevity Thematic Index. The fund invests more than 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies in developed markets that facilitate the demographic trend of longer average life spans and the aging of the global population, including but not limited to companies involved in biotechnology, medical devices, pharmaceuticals, senior living facilities and specialized health care services.
    Biotechnology Structured Finance Pharmaceutical Financial Market Health Care Services
    Back to the Main AGNG Page...